Natural killer cell immunotherapy to target stem-like tumor cells

Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells

(2015) Min Xu et al.   CANCER LETTERS

A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors

(2015) Antonio Pérez-Martínez et al.   CYTOTHERAPY

NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

(2015) Erik Ames et al.   JOURNAL OF IMMUNOLOGY

Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

(2015) Naoyuki Sakamoto et al.   Journal of Translational Medicine

Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells

(2015) Erik Ames et al.   OncoImmunology

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma

(2014) Robert J Canter et al.   BMC CANCER

Tackling the cancer stem cells — what challenges do they pose?

(2014) Diwakar R. Pattabiraman et al.   NATURE REVIEWS DRUG DISCOVERY

Natural Killer Cell Subsets Differentially Reject Embryonic Stem Cells Based on Licensing

(2014) Jessica Perez-Cunningham et al.   TRANSPLANTATION

The Clinical Relevance of Cancer Cell Lines

(2013) J.-P. Gillet et al.   JNCI-Journal of the National Cancer Institute

NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties

(2009) R. Castriconi et al.   JOURNAL OF IMMUNOLOGY